INS and diabetes mellitus: The intraperitoneal STZ injection induced hyperglycaemia (diabetes) in rats by damaging the pancreatic β-cell function, resulting in significantly decreased serum insulin concentration (by 73 %), increased plasma glucose level (by 46 %) as well as decreased serum Zn concentration (by 20 %).